<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3087">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01795001</url>
  </required_header>
  <id_info>
    <org_study_id>S55133</org_study_id>
    <nct_id>NCT01795001</nct_id>
  </id_info>
  <brief_title>The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy</brief_title>
  <official_title>The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fund for Scientific Research, Flanders, Belgium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Funds for Research in Ophthalmology, Belgium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mieke Perdaens fund for Eye Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to gain further insights into the molecular pathogenesis of
      Fuchs' endothelial corneal dystrophy (FECD), to identify targets for potential specific drug
      therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control</study_design>
  <primary_outcome>
    <measure>cytokine levels</measure>
    <time_frame>at time of prelevation (once, no intervention)</time_frame>
    <safety_issue>No</safety_issue>
    <description>dosage of cytokine levels in aqueous humour (exploratory, non-interventional study)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>gene expression levels</measure>
    <time_frame>at time of prelevation (once, no intervention)</time_frame>
    <safety_issue>No</safety_issue>
    <description>microarray expression analysis and RT-qPCR (exploratory, non-interventional study)</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">330</enrollment>
  <condition>Fuchs' Endothelial Dystrophy</condition>
  <arm_group>
    <arm_group_label>FECD</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>normal control</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non-FECD oedematous control</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Non-interventional study on corneal endothelium, anterior eye chamber fluid and
      paraffin-embedded corneal tissue, using molecular techniques to identify and characterise
      the molecular players involved in the pathogenesis of FECD.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Fuchs' Endothelial Corneal Dystrophy (FECD), normal control patients, and
        patients with non-Fuchs oedematous corneas; in university hospital setting.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  FECD

        Exclusion Criteria:

          -  ocular infection or other ocular disease (other than FECD)

          -  ocular surgery in the past 3 weeks

          -  prior ocular irradiation therapy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joost J van den Oord, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KU Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Translational Cell and Tissue Research - campus Sint-Raf - UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>An-Katrien De Roo</last_name>
      <phone>+32 16 33 65 88</phone>
    </contact>
    <investigator>
      <last_name>Joost J van den Oord, prof. dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Beatrijs Foets, prof. dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>An-Katrien De Roo, dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 7, 2014</lastchanged_date>
  <firstreceived_date>January 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Corneal Dystrophies, Hereditary</mesh_term>
    <mesh_term>Fuchs' Endothelial Dystrophy</mesh_term>
    <mesh_term>Iridocorneal Endothelial Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
